The effectiveness of a PRF-DRG treatment on radicular neuropathic pai
- Conditions
- neuralgiaRadicular neuropathic pain10034606
- Registration Number
- NL-OMON40047
- Lead Sponsor
- Medisch Spectrum Twente
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 46
-Subjects should have lumbar of sacral radicular neuropathic pain in dermatome L4, L5 or S1 where the pain is limited for 1 dermatome for at least 3 months. The subjects should have a pain reduction of minimum 50% with a VAS score from 0 to 10 after a diagnostic block.
- Subject is between 18 and 75 year
- Subject has a pain score of 4 or above (visual analog scale, VAS: 0-10 from no pain to worst pain).
- Subject has no new pain medication 2 weeks before the treatment.
- Informed consent.
- Subject has sensory deficits at the QST site resulting from such medical conditions such as diabetes, alcoholic neuropathy, AIDS neuropathy, severe thyroid, liver or kidney diseases.
- Former PRF and RF treatment of the same nerve root.
- Subject has scar tissue, infection, or acute injury at the QST site.
- Language barriers and other problems impairing the reliable completion of questionnaires.
- Subject is pregnant.
- Subject has a pacemaker.
- Subject has a major psychiatric disease or dementia.
- History of back surgery.
- Other chronic pain (such as fibromyalgia).
- Anticoagulation in form of vitamin K antagonists which should not be stopped.
- Skin diseases (such as herpes zoster, burns etc.)
- Allergy for contrast or lidocaine
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Electrical sensation thresholds before and after PRF treatment </p><br>
- Secondary Outcome Measures
Name Time Method <p>VAS score, symptoms of pain (pain detect), medication use, HADS and RAND-36<br /><br>questionnaire</p><br>